CREDIT SUISSE AG/ - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$37,000
-90.5%
27,252
-89.1%
0.00%
Q3 2016$389,000
-6.9%
249,597
-20.6%
0.00%
Q2 2016$418,000
-73.0%
314,181
+7.1%
0.00%
-100.0%
Q1 2016$1,546,000
-10.9%
293,447
+32.8%
0.00%0.0%
Q4 2015$1,735,000
-17.9%
220,981
-11.5%
0.00%
-33.3%
Q3 2015$2,112,000
-32.9%
249,792
-13.1%
0.00%0.0%
Q2 2015$3,149,000
-0.3%
287,603
+27.3%
0.00%0.0%
Q1 2015$3,158,000
+4.1%
225,839
+25.8%
0.00%0.0%
Q4 2014$3,033,000
+43.5%
179,530
+14.0%
0.00%
+50.0%
Q3 2014$2,113,000
-54.2%
157,438
-56.5%
0.00%
-50.0%
Q2 2014$4,611,000
-20.4%
361,958
-25.7%
0.00%
-20.0%
Q1 2014$5,791,000
+10.0%
487,157
+27.8%
0.01%
+25.0%
Q4 2013$5,265,000
+25.7%
381,251
+58.6%
0.00%0.0%
Q3 2013$4,189,000
+22.5%
240,326
+13.8%
0.00%
+33.3%
Q2 2013$3,420,000
+158.9%
211,171
+675.2%
0.00%
+200.0%
Q1 2013$1,321,00027,2410.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,100,000$14,762,0006.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,882,805$52,107,0001.90%
Cheyne Capital Management (UK) LLP 326,821$4,388,0001.56%
BB BIOTECH AG 2,320,737$31,144,0001.27%
Broadfin Capital, LLC 854,384$11,466,0001.20%
HealthCor Management, L.P. 1,162,200$15,597,0000.80%
Orbimed Advisors 4,736,900$63,569,0000.66%
Rhenman & Partners Asset Management AB 148,000$1,986,0000.58%
SOUND ENERGY PARTNERS, INC. 51,000$684,0000.53%
Rock Springs Capital Management LP 210,000$2,818,0000.44%
View complete list of INFINITY PHARMACEUTICALS INC shareholders